2025 Neuropsychiatry Biomarkers Investigation Intern

Learn more about AbbVie
AbbVie

AbbVie

2025 Neuropsychiatry Biomarkers Investigation Intern

North Chicago, IL
Internship
Paid
  • Responsibilities

    Company Description

    AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas – immunology, oncology, neuroscience, and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

    Job Description

    Neuropsychiatry Biomarkers Investigation Internship Overview

    Envision spending your summer working with energetic colleagues and inspirational leaders, all while gaining world-class experience in one of the most dynamic organizations in the pharmaceutical industry. This is a reality for AbbVie Interns.

    With recent acquisitions, Abbvie has several programs coming into our pipeline for major depressive disorders (MDD) and Schizophrenia. The internship project will be initiated by mining publicly available datasets to identify novel biomarkers within the pathways of interest and potential new targets to pursue. Functional validation in cell line models will provide support for the subset of markers that may be used in Abbvie clinical trials for patient recruitment, stratification, or for post hoc analyses. Further, the intern will utilize samples available from current clinical trials as well as procured samples to generate proteomic and transcriptomic data to identify novel markers and to validate previous hits. This cross-functional work will be done in collaboration with the Neuroscience Discovery, Precision Medicine, and Neuroscience Clinical Development departments.

    Key responsibilities include:

    • Mining public data to identify potential novel biomarkers
    • Evaluation of biomarker(s) in cell line models, potentially iPSCs
    • Omics analysis of patient samples
    • Biological interpretation of the data

    Qualifications

    Minimum Qualifications

    • Currently enrolled in university, pursuing a PharmD or PhD in Molecular Biology, Biological Sciences, Biochemistry or other related field
    • Must be enrolled in university for at least one semester following the internship

    Preferred Qualifications

    • Expected graduation date between December 2025 – July 2026
    • Exposure to the neuropsychiatry disease area
    • Cell culture experience
    • Passion for translating research to drug development processes (bench to bedside)

    Benefits and Amenities

    • Competitive pay
    • Relocation support for eligible students
    • Select wellness benefits and paid holiday / sick time
    • Opportunity to work with a very driven, diverse team with expertise in various fields
    • Ability to support a project that provides a translational view of how drug development works

    Equal Employment Opportunity

    At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.

    Additional Information

    Applicable only to applicants applying to a position in any location with pay disclosure requirements under state or local law: ​

    • The compensation range described below is the range of possible base pay compensation that the Company believes in good faith it will pay for this role at the time of this posting based on the job grade for this position. Individual compensation paid within this range will depend on many factors including geographic location, and we may ultimately pay more or less than the posted range. This range may be modified in the future.​

    Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, benefits, or any other form of compensation and benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.

    AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives, serving our community and embracing diversity and inclusion. It is AbbVie’s policy to employ qualified persons of the greatest ability without discrimination against any employee or applicant for employment because of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information, gender identity or expression, sexual orientation, marital status, status as a protected veteran, or any other legally protected group status.

    US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html

    US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:

    https://www.abbvie.com/join-us/reasonable-accommodations.html

    Salary: $58,656 - $98,000

  • Compensation
    $58,656-$98,000 per year
  • Industry
    Pharmaceuticals
  • About Us

    AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.